NBRV - Nabriva Therapeutics plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue9,6565,3196,4823,767
Cost of Revenue50,24049,61547,99423,604
Gross Profit-40,584-44,296-41,512-19,837
Operating Expenses
Research Development----
Selling General and Administrative41,74329,47213,5357,921
Non Recurring----
Others----
Total Operating Expenses91,98379,08761,52931,525
Operating Income or Loss-82,327-73,768-55,047-27,758
Income from Continuing Operations
Total Other Income/Expenses Net-32,404767-515-19,651
Earnings Before Interest and Taxes-82,327-73,768-55,047-27,758
Interest Expense-133-43-75-22,092
Income Before Tax-114,731-73,001-55,562-47,409
Income Tax Expense491,355-672-445
Minority Interest----
Net Income From Continuing Ops-114,780-74,356-54,890-46,964
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-114,780-74,356-54,890-46,964
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-114,780-74,356-54,890-50,839